#Study ID	GSE65209
#Platform ID	GPL7137
#Platform Data Column Numbers	2
#Outside study controls	
#Difference Calculation	Subtraction
#Comparison Calculation	Mean
#In-column Delimiter	,
#Add N Samples	14
Sample_ID	Group	Species	Strain	Growth_Phase	Other_General	Treatment	Dosage	Exposure_Time	Other_Treatment
GSM1589603	Control	S. aureus	USA300 FPR3757	log					
GSM1589604	Control	S. aureus	USA300 FPR3757	log					
GSM1589605	Control	S. aureus	USA300 FPR3757	log					
GSM1589606	Control	S. aureus	USA300 FPR3757	transient					
GSM1589607	Control	S. aureus	USA300 FPR3757	transient					
GSM1589608	Control	S. aureus	USA300 FPR3757	transient					
GSM1589609	Test	S. aureus	USA300 FPR3757	transient		Linezolid	5 μg/mL		OD 0.9|Bacteriostatic,MRSA
GSM1589610	Test	S. aureus	USA300 FPR3757	transient		Linezolid	5 μg/mL		OD 0.9|Bacteriostatic,MRSA
GSM1589611	Test	S. aureus	USA300 FPR3757	transient		Linezolid	5 μg/mL		OD 0.9|Bacteriostatic,MRSA
GSM1589612	Test	S. aureus	USA300 FPR3757	stationary		Linezolid	5 μg/mL		OD 1.8|Bacteriostatic,MRSA
GSM1589613	Test	S. aureus	USA300 FPR3757	stationary		Linezolid	5 μg/mL		OD 1.8|Bacteriostatic,MRSA
GSM1589614	Test	S. aureus	USA300 FPR3757	stationary		Linezolid	5 μg/mL		OD 1.8|Bacteriostatic,MRSA
GSM1589615	Test	S. aureus	USA300 FPR3757	transient		Linezolid	5 μg/mL		OD 2.2|Bacteriostatic,MRSA
GSM1589616	Test	S. aureus	USA300 FPR3757	transient		Linezolid	5 μg/mL		OD 2.2|Bacteriostatic,MRSA
GSM1589617	Test	S. aureus	USA300 FPR3757	transient		Linezolid	5 μg/mL		OD 2.2|Bacteriostatic,MRSA